About 1,293,995 results (5,502 milliseconds)

WO2011085040A1 - System and method for managing medical data ...

https://patents.google.com/patent/WO2011085040A1/en
Table 2: Examples of ICD Codes for Diabetes. ICD Codes for Diabetes Description ... 2 type II or unspecified type, uncontrolled Use additional code, if ...

3.Clinical_Entity_Resolvers.ipynb - Colab

https://colab.research.google.com/github/JohnSnowLabs/spark-nlp-workshop/blob/master/tutorials/Certification_Trainings/Healthcare/3.Clinical_Entity_Resolvers.ipynb
Each HCC is mapped to an ICD-10 code. Along with demographic ... type 2 diabetes mellitus [type 2 diabetes mellitus with circulatory complications]] ...

EP1718602A1 - Therapeutic and carrier molecules - Google Patents

https://patents.google.com/patent/EP1718602A1/en
The data, expressed as % of control, are presented as mean ± SEM of 10 and 5 mice for DTH and peritoneal inflammation, respectively. Analysis of data by two- ...

WO2018039642A1 - Compositions and methods thereof - Google ...

https://patents.google.com/patent/WO2018039642A1/en
Pharmaceutical compositions comprising a compound of formula I and a compound of Formula II: (IIa) (IIb) or enantiomers thereof, metabolites thereof, ...

WO2004011460A2 - Pyrazolylbenzothiazole derivatives and their ...

https://patents.google.com/patent/WO2004011460A2/de
... 10 mM MgCI 2 , 1 mM MnCI , 5 uM ⁇ -methyl aspartic acid, 2 mM NaF) and ... Methods and compositions for treating diabetes and diabetic complications.

US8754233B2 - Pyrazolylbenzothiazole derivatives and their use as ...

https://patents.google.com/patent/US8754233B2/en
After stirring for 40 minutes, a solution of potassium thiocyanate (1.0 g, 10 mmol) in 2 mL of water was added. ... for treating diabetes and diabetic ...

BR112021003265A2 - Methods to Reduce Diabetes Risk in Patients ...

https://patents.google.com/patent/BR112021003265A2/en
METHODS TO REDUCE THE RISK OF DIABETES IN PATIENTS BEING TREATED FOR HIGH CHOLESTEROL-RELATED DISEASES. The present invention relates to compositions ...

KR20190042056A - Composition and method thereof - Google ...

https://patents.google.com/patent/KR20190042056A/en
... type 2 diabetes mellitus. Thromb Res 70 (2): 131-8 (1993); Ogawa et al ... PLoS One 10 (2): e0117792 (2015 In a case-control study in Chinese subjects ...

EP2461694A2 - Treatment of macrophage-related disorders ...

https://patents.google.com/patent/EP2461694A2/en
[0024] In some embodiments, the second therapeutic agent comprises a therapeutic agent for treating type II diabetes or related complications. Such agents ...

WO2005026358A9 - Polymorphisms in selenoprotein s - Google ...

https://patents.google.com/patent/WO2005026358A9/en
PCR conditions were 50°C for 2 min, 95°C for 10 min followed by 40 cycles of ... Of the 20 type I diabetics, 20 type II diabetics and 17 normoglycaemic ...

US20140303901A1 - Method and system for predicting a disease ...

https://patents.google.com/patent/US20140303901A1/en
A human genome contains 22 autosomes and a pair of sex chromosome (X and Y in male, and two Xs in female). [0005]. A gene is the genetic information unit of ...

WO2003045379A1 - Hydrazonopyrazole derivatives and their use ...

https://patents.google.com/patent/WO2003045379A1/en
Such conditions include those associated with defects in cell cycle regulation or in response to extracellular signals, e.g. hyperglycemia and diabetes Type I ...

US20050154374A1 - Implantable sensors and implantable pumps ...

https://patents.google.com/patent/US20050154374A1/en
... for both type 1 and type 2 diabetics. This device may also include a unique ... The dose per unit area of 0.1 μg-100 μg per mm 2; preferred dose of 0.5 μg/mm 2-10 ...

CA2246431A1 - Recombinant expression of proteins from secretory ...

https://patents.google.com/patent/CA2246431A1/en
Fusions are generated by linking together the coding regions for two proteins, or parts of two ploteins. ... diabetes, it is likely that this type of diabetes ...

PT1678194E - The modulation of hyaluronan synthesis and ...

https://patents.google.com/patent/PT1678194E/en
Cells were loaded at 2.5x10 5 / cells in 25 cm 2 culture flasks and incubated at 37 ° C for 24h, 48h, 72h, 96h, 120h and 144h. At each point in time, the cells ...

KR20180095935A - Bromo-domain and extra-terminal protein ...

https://patents.google.com/patent/KR20180095935A/en
The present invention relates to compositions and methods for the treatment of cancer, such as glioblastoma and non-Hodgkin's lymphoma, or other cancers in ...

HOMSIDHMEDICS - STANDARD TREATMENT GUIDELINES IN ...

https://sites.google.com/view/homsidhmedics/homeopathy/standard-treatment-guidelines-in-homoeopathy
... Type 2 diabetes orNon-insulin dependent diabetes or adultonset diabetes. Risk Factors for Type-2 ... uncontrolled hyperglycemia is positive for ketone bodies.

Database in progress: Statins Registries - ClinicalTrials.gov - Search ...

https://docs.google.com/spreadsheets/d/1HhsYOiQA0QXhk86WthuxRoOxBPIWujdxWrYtgDg1LvY
NCT00548639, The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients ... 10 mg in Type IIa and IIb Hypercholesterolaemic Patients. Completed, Has Results.

Severe Sepsis and Septic Shock: Review of the Literature and ...

https://groups.google.com/group/residencianotti/attach/40b830d73c7385ae/NGUYEN%20-%20AEM%202006%20-%20SEPSIS%20SEVERA%20Y%20SHOCK%20SEPTICO%20EN%20EMERGENCIA%20REVISION.pdf?part=0.5
Jan 20, 2006 ... The need for an emergency. 28 Annals of Emergency Medicine. Volume 48, no. 1 : July 2006. Page 2. medicine–based review and recommendations was ...